Facilitated By

San Antonio Medical Foundation

mHealth for Patient Self-Management of Opioid Use Disorder

Biomedical Development Corporation

For more than 25 years, Biomedical Development Corporation has been bringing commercially-viable products to market by linking promising technologies with vital sources of research funding.

Principal Investigator(s)
Jennifer Sharpe Potter, Ph.D.
Collaborating Institutions
UT Health San Antonio
Funded by
NIH / NIDA
Research Start Date
Status
Active

This Phase II STTR project furthers the development of KIOS, a digital therapeutic for the treatment of opioid use disorder (OUD). The product to be commercialized is an FDA-approved digital therapeutic (DTx) medical device offered adjunctive to medication assisted therapy (MAT). In contrast to other digital products for OUD, only KIOS offers continuously available, individualized, evidence-based behavioral intervention strategies responsive to a patient's current clinical status outside the context of the doctor’s office or treatment facility.

Collaborative Project
Medical Devices
Behavioral Health